Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hennig

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Journal of the American Chemical Society|November 13, 2024
Kinetic Basis for the Design of Azobenzene-Based Photoswitchable A<sub>2a</sub> Adenosine Receptor LigandsTorben Saßmannshausen, Hannah Glover, Matilde Trabuco, et al.
Journal of Hypertension|May 17, 2005
Carotid wall composition in hypertensive patients after 4-year treatment with lacidipine or atenolol: an echoreflectivity studyRoberta Paliotti, Michele M Ciulla, Michael Hennig, et al.
Circulation|September 10, 2009
Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA)Alberto Zanchetti, Michael Hennig, Regina Hollweck, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 1, 2019
Persistence and adherence to dutasteride/tamsulosin fixed-dose versus free-combination alpha blocker/5ARI therapy in patients with benign prostate hyperplasia in Germany
Christoph Eisen, Zrinka Lulic, Juan Manuel Palacios-Moreno, et al.
Journal of Asthma and Allergy|May 17, 2023
Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study)Stephanie Korn, Katrin Milger, Dirk Skowasch, et al.
Nature|November 5, 2004
Insight into steroid scaffold formation from the structure of human oxidosqualene cyclaseRalf Thoma, Tanja Schulz-Gasch, Brigitte D'Arcy, et al.
Bioorganic & Medicinal Chemistry|September 12, 2007
Is adamantane a suitable substituent to pre-organize the acid orientation in E-selectin antagonists?Alexander Titz, John Patton, André M Alker, et al.
Audiology & Neuro-Otology|December 14, 2004
Novel slow- and fast-type drug release round-window microimplants for local drug application to the cochlea: an experimental study in guinea pigsWolfgang Arnold, Pascal Senn, Michael Hennig, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 1, 2022
Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes? An ISPOR Special Interest Group ReportMichael Schlichting, Michael Hennig, Katja Rudell, et al.
International Journal of Cancer|June 25, 2011
Humoral response to catumaxomab correlates with clinical outcome: results of the pivotal phase II/III study in patients with malignant ascitesMarion G Ott, Frederik Marmé, Gerhard Moldenhauer, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Journal of the American Chemical Society|November 13, 2024
Kinetic Basis for the Design of Azobenzene-Based Photoswitchable A<sub>2a</sub> Adenosine Receptor LigandsTorben Saßmannshausen, Hannah Glover, Matilde Trabuco, et al.
Journal of Hypertension|May 17, 2005
Carotid wall composition in hypertensive patients after 4-year treatment with lacidipine or atenolol: an echoreflectivity studyRoberta Paliotti, Michele M Ciulla, Michael Hennig, et al.
Circulation|September 10, 2009
Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA)Alberto Zanchetti, Michael Hennig, Regina Hollweck, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 1, 2019
Persistence and adherence to dutasteride/tamsulosin fixed-dose versus free-combination alpha blocker/5ARI therapy in patients with benign prostate hyperplasia in Germany
Christoph Eisen, Zrinka Lulic, Juan Manuel Palacios-Moreno, et al.
Journal of Asthma and Allergy|May 17, 2023
Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study)Stephanie Korn, Katrin Milger, Dirk Skowasch, et al.
Nature|November 5, 2004
Insight into steroid scaffold formation from the structure of human oxidosqualene cyclaseRalf Thoma, Tanja Schulz-Gasch, Brigitte D'Arcy, et al.
Bioorganic & Medicinal Chemistry|September 12, 2007
Is adamantane a suitable substituent to pre-organize the acid orientation in E-selectin antagonists?Alexander Titz, John Patton, André M Alker, et al.
Audiology & Neuro-Otology|December 14, 2004
Novel slow- and fast-type drug release round-window microimplants for local drug application to the cochlea: an experimental study in guinea pigsWolfgang Arnold, Pascal Senn, Michael Hennig, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 1, 2022
Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes? An ISPOR Special Interest Group ReportMichael Schlichting, Michael Hennig, Katja Rudell, et al.
International Journal of Cancer|June 25, 2011
Humoral response to catumaxomab correlates with clinical outcome: results of the pivotal phase II/III study in patients with malignant ascitesMarion G Ott, Frederik Marmé, Gerhard Moldenhauer, et al.
Pageof 9